Alpine Peaks Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celsius Holdings
CELH
|
+$830K |
| 2 |
Jack Henry & Associates
JKHY
|
+$317K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$3.27M |
| 2 |
Littelfuse
LFUS
|
+$2.69M |
| 3 |
Qualys
QLYS
|
+$2.44M |
| 4 |
Cognex
CGNX
|
+$1.96M |
| 5 |
TriNet
TNET
|
+$1.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.82% |
| 2 | Industrials | 25.8% |
| 3 | Healthcare | 25.61% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Consumer Staples | 4.27% |
No holdings matched the selected filter criteria.
Similar funds
Alpine Peaks Capital's Q2 2026 Portfolio in Review
As of Q2 2026, Alpine Peaks Capital held 22 positions worth $85.4M, down 14% from $99.2M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Alpine Peaks Capital withdrew a net $23.5M in Q2 2026, closing 2 positions and reducing 18 holdings. Its most notable exit was TriNet, an estimated $1.66M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Alpine Peaks Capital opened a new position in Celsius Holdings worth $771K.
- Alpine Peaks Capital's largest Q2 2026 buy was Celsius Holdings: 26,332 shares worth $771K.
- Alpine Peaks Capital added most to Jack Henry & Associates in Q2 2026, an estimated $317K increase.
- Alpine Peaks Capital's biggest Q2 2026 reduction was West Pharmaceutical, cutting an estimated $3.27M.
- Alpine Peaks Capital fully exited TriNet in Q2 2026, selling an estimated $1.66M.
- Alpine Peaks Capital's ten largest holdings make up 65% of its $85.4M portfolio in Q2 2026.
- Alpine Peaks Capital opened 1 new position and closed 2 in Q2 2026.
- Alpine Peaks Capital's portfolio value fell 14% quarter-over-quarter to $85.4M.
Based on Alpine Peaks Capital's 13F filing for Q2 2026, filed 14 Aug 2026.